Clinical Trials Browser

Phase 3 × Rectal Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00265824 2015-12-11

DREAM

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms